Contrasting systemic stabilities of the acyl and phenolic glucuronides of diflunisal in the rat
- 1 January 1991
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 21 (3) , 403-415
- https://doi.org/10.3109/00498259109039480
Abstract
1. Diflunisal (DF) is metabolized in humans and rats primarily to its acyl glucuronide, phenolic glucuronide and sulphate conjugates. 2. After i.v. administration of DF acyl glucuronide to pentobarbitone-anaesthetized rats, DF and its phenolic glucuronide and sulphate conjugates appeared rapidly in plasma, indicating ready systemic hydrolysis of the acyl glucuronide and subsequent biotransformation of liberated DF. 3. Approximately 72% of the acyl glucuronide dose was recovered in bile and urine over 6 h: 52% as acyl glucuronide, 6% as phenolic glucuronide, 5% as sulphate, and 8% as isomers of the acyl glucuronide arising from intramolecular acyl migration. 4. Blockage of excretion routes by ligation of the ureters, bile duct, and both ureters and bile duct, decreased plasma clearance of the acyl glucuronide from 7.8 ml/min per kg to 6.0, 3.2 and 2.2 ml/min per kg respectively, and increased the apparent terminal plasma half-life of DF from 2.1 h to 2.6, 3.4 and 6.3 h, respectively. 5. By contrast, DF phenolic glucuronide was quite stable after i.v. administration at the same dose. 6. This study shows that systemic cycling between DF and its acyl glucuronide exists in the rat in vivo, with portions of each cycle of unstable acyl glucuronide through DF yielding stable phenolic glucuronide and (presumptively stable) sulphate conjugate.Keywords
This publication has 29 references indexed in Scilit:
- ELIMINATION OF DIFLUNISAL AS ITS ACYL GLUCURONIDE, PHENOLIC GLUCURONIDE AND SULFATE CONJUGATES IN BILE‐EXTERIORIZED AND INTACT RATSClinical and Experimental Pharmacology and Physiology, 1989
- Reactivity Considerations in the Analysis of Glucuronide and Sulfate Conjugates of DiflunisalTherapeutic Drug Monitoring, 1989
- Effect of dose on the glucuronidation and sulphation kinetics of diflunisal in man: single dose studies.British Journal of Clinical Pharmacology, 1988
- Isolation and identification of the rearrangement products of diflunisal 1-O-acyl glucuronideJournal of Pharmaceutical and Biomedical Analysis, 1988
- Reversed-phase high-performance liquid chromatographic assay for the simultaneous determination of diflunisal and its glucuronides in serum and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- Rearrangement of Valproate Glucuronide in a Patient with Drug‐Associated Hepatobiliary and Renal DysfunctionEpilepsia, 1985
- Assay methodology for quantification of the ester and ether glucuronide conjugates of diflunisal in human urineJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Properties of Acyl Glucuronides: Implications for Studies of the Pharmacokinetics and Metabolism of Acidic DrugsDrug Metabolism Reviews, 1984
- Decreased clearance of diflunisal in renal insufficiency—an alternative explanation [letter]British Journal of Clinical Pharmacology, 1980
- Decreased body clearance of diflunisal in renal insufficiency‐an alternative explanation [letter]British Journal of Clinical Pharmacology, 1979